Protective HLA Alleles Against Severe COVID-19: HLA-A*68 As an Ancestral Protection Allele in Tapachula-Chiapas, Mexico

HLA is a polymorphic antigen presenter which has provided valuable information on the susceptibility of populations to viruses. Therefore, the study of HLA can reveal specific susceptibility or resistance alleles to severe COVID-19 in an ethnically dependent manner. This pilot study investigated HLA alleles associated with COVID-19 severity in Tapachula, Chiapas, Mexico. A total of 146 Mexican Mestizos were typed for HLA class I and II using PCR-SSP. The patients were classified according to the outcome (death or improvement) and the infection's severity (mild or severe). In addition, a group of exposed uninfected individuals was included. HLA-A*68 was found to be a protective allele against the severe infection and fatal outcome; pC = 0.03, OR = 0.4, 95% CI =0.20-0.86, and pC =0.009, OR = 0.3, 95% CI =0.13-0.71 respectively. HLA-DRB1*03 also appears to be a protective factor against fatal outcome pC = 0.009, OR = 0.1, 95%IC = 0.01-0.66; however, the low frequency of this allele in the studied population limits the statistical power. The severity and fatal outcome of COVID-19 patients in Tapachula, Chiapas depend more on the lack of resistance than susceptibility HLA alleles.

Citing Articles

Genetic diversity of the immunoglobulin heavy chain locus in cohorts of patients affected with SARS-CoV-2.

Malaspina P, Jodice C, Ciminelli B, Biancolella M, Colona V, Latini A Hum Genomics. 2025; 19(1):7.

PMID: 39885568 PMC: 11780896. DOI: 10.1186/s40246-025-00719-8.

T cell-mediated Immune response and correlates of inflammation and their relationship with COVID-19 clinical severity: not an intuitive guess.

Pena N, Santana L, Hunter J, Blum V, Vergara T, Gouvea C BMC Infect Dis. 2024; 24(1):612.

PMID: 38902613 PMC: 11191252. DOI: 10.1186/s12879-024-09490-y.

Narrative Review Explaining the Role of , , and Molecules in COVID-19 Disease in and around Africa.

Naidoo L, Arumugam T, Ramsuran V Infect Dis Rep. 2024; 16(2):380-406.

PMID: 38667755 PMC: 11049896. DOI: 10.3390/idr16020029.

Risk factors contributing to infection with SARS-CoV-2 are modulated by sex.

Lecona O, Arroyo-Valerio A, Bueno-Hernandez N, Carrillo-Ruiz J, Ruelas L, Marquez-Franco R PLoS One. 2024; 19(2):e0297901.

PMID: 38416704 PMC: 10901358. DOI: 10.1371/journal.pone.0297901.

The Influence of HLA Polymorphisms on the Severity of COVID-19 in the Romanian Population.

Vica M, Dobreanu M, Curocichin G, Matei H, Balici S, Vuscan M Int J Mol Sci. 2024; 25(2).

PMID: 38279325 PMC: 10816224. DOI: 10.3390/ijms25021326.

References

Amoroso A, Magistroni P, Vespasiano F, Bella A, Bellino S, Puoti F . HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity. Transplantation. 2020; 105(1):193-200. DOI: 10.1097/TP.0000000000003507. View

Novelli A, Andreani M, Biancolella M, Liberatoscioli L, Passarelli C, Colona V . HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients. HLA. 2020; 96(5):610-614. PMC: 7461491. DOI: 10.1111/tan.14047. View

Falfan-Valencia R, Narayanankutty A, Resendiz-Hernandez J, Perez-Rubio G, Ramirez-Venegas A, Nava-Quiroz K . An Increased Frequency in HLA Class I Alleles and Haplotypes Suggests Genetic Susceptibility to Influenza A (H1N1) 2009 Pandemic: A Case-Control Study. J Immunol Res. 2018; 2018:3174868. PMC: 5845504. DOI: 10.1155/2018/3174868. View

Martinetti M, De Silvestri A, Belloni C, Pasi A, Tinelli C, Pistorio A . Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol. 2000; 97(3):234-40. DOI: 10.1006/clim.2000.4933. View

Pairo-Castineira E, Clohisey S, Klaric L, Bretherick A, Rawlik K, Pasko D . Genetic mechanisms of critical illness in COVID-19. Nature. 2020; 591(7848):92-98. DOI: 10.1038/s41586-020-03065-y. View

Yin L, Calvo-Calle J, Dominguez-Amorocho O, Stern L . HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives. J Immunol. 2012; 189(8):3983-94. PMC: 3466378. DOI: 10.4049/jimmunol.1200626. View

Wang J, Zheng X, Ke X, Dorak M, Shen J, Boodram B . Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection. Virol J. 2009; 6:46. PMC: 2679741. DOI: 10.1186/1743-422X-6-46. View

Morsy S . NCAM protein and SARS-COV-2 surface proteins: In-silico hypothetical evidence for the immunopathogenesis of Guillain-Barré syndrome. Med Hypotheses. 2020; 145:110342. PMC: 7543761. DOI: 10.1016/j.mehy.2020.110342. View

Vargas-Alarcon G, Hernandez-Pacheco G, Zuniga J, Rodriguez-Perez J, Perez-Hernandez N, Rangel C . Distribution of HLA-B alleles in Mexican Amerindian populations. Immunogenetics. 2003; 54(11):756-60. DOI: 10.1007/s00251-002-0522-0. View

10.

Vargas-Alarcon G, Salgado N, Granados J, Gomez-Casado E, Martinez-Laso J, Alcocer-Varela J . Class II allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: the relevance of considering homologous chromosomes in determining susceptibility. Hum Immunol. 2001; 62(8):814-20. DOI: 10.1016/s0198-8859(01)00267-1. View

11.

Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X . COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020; 27(5):1451-1454. PMC: 7091918. DOI: 10.1038/s41418-020-0530-3. View

12.

Zhou Z, Reyes-Vargas E, Escobar H, Rudd B, Rockwood A, Delgado J . Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides. Eur J Immunol. 2015; 46(4):834-45. PMC: 4828309. DOI: 10.1002/eji.201545942. View

13.

Nguyen A, David J, Maden S, Wood M, Weeder B, Nellore A . Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2. J Virol. 2020; 94(13). PMC: 7307149. DOI: 10.1128/JVI.00510-20. View

14.

Cammarata-Scalisi F, Tadich A, Callea M . Genetic variability in the case of COVID-19 infection. Arch Argent Pediatr. 2020; 118(5):304-305. DOI: 10.5546/aap.2020.eng.304. View

15.

Barquera R, Juarez-Nicolas F, Martinez-Alvarez J, Ponnandai-Shanmugavel K, Hernandez-Zaragoza D, Vazquez-Castillo T . Genetic diversity of HLA system in two populations from Chiapas, Mexico: Tuxtla Gutiérrez and rural Chiapas. Hum Immunol. 2019; 81(9):563-565. DOI: 10.1016/j.humimm.2019.07.285. View

16.

Garcia-Silva R, Hernandez-Dono S, Mena L, Granados J . MEXICAN HUMAN LEUKOCYTE ANTIGEN ALLELES MIGHT PREDICT CLINICAL OUTCOME IN SARS-COV-2 INFECTED PATIENTS. Rev Invest Clin. 2020; 72(3):178-179. DOI: 10.24875/RIC.20000135. View

17.

Layrisse Z, Guedez Y, Dominguez E, Paz N, Montagnani S, Matos M . Extended HLA haplotypes in a Carib Amerindian population: the Yucpa of the Perija Range. Hum Immunol. 2001; 62(9):992-1000. DOI: 10.1016/s0198-8859(01)00297-x. View

18.

Sumnik Z, Cinek O, Bratanic N, Kordonouri O, Kulich M, Roszai B . Risk of celiac disease in children with type 1 diabetes is modified by positivity for HLA-DQB1*02-DQA1*05 and TNF -308A. Diabetes Care. 2006; 29(4):858-63. DOI: 10.2337/diacare.29.04.06.dc05-1923. View

19.

Kurane I, Okamoto Y, Dai L, Zeng L, Brinton M, Ennis F . Flavivirus-cross-reactive, HLA-DR15-restricted epitope on NS3 recognized by human CD4+ CD8- cytotoxic T lymphocyte clones. J Gen Virol. 1995; 76 ( Pt 9):2243-9. DOI: 10.1099/0022-1317-76-9-2243. View

20.

Mellins E, Stern L . HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation. Curr Opin Immunol. 2014; 26:115-22. PMC: 3944065. DOI: 10.1016/j.coi.2013.11.005. View